logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Cipher Pharmaceuticals Inc.

CPH.TO

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic aā€¦ read more

Healthcare

Drug Manufacturersā€”Specialty & Generic

19 years

CAD

Exclusive to Premium users

Price

per share adjusted in CAD

$14.22

Price

-1.25%

-$0.18

$14.40

Previous Close

$14.47

Open

Premium

52w Discount
Market Cap

$364.358m

Small

Price/Earnings

22.6x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$39.515m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

$9.246m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

$0.37

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$102.343m

$162.512m

Assets

$60.169m

Liabilities

$40.578m

Debt
Debt to Assets

25.0%

3.2x

Debt to EBITDA
Free Cash Flow

$19.502m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
ā†‘ TopSummaryPriceFinancials
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.